<DOC>
	<DOCNO>NCT00709046</DOCNO>
	<brief_summary>The study design evaluate efficacy adjuvant use standard dose high dose proton pump inhibitor combine endoscopic hemostasis therapy .</brief_summary>
	<brief_title>High Dose Versus Standard Dose Proton Pump Inhibitor ( PPI ) High-risk Bleeding Peptic Ulcers After Combined Endoscopic Treatment</brief_title>
	<detailed_description>Acute peptic ulcer bleeding remain common cause acute upper gastrointestinal bleeding . Endoscopy serve tool initial diagnosis triage also tool immediate hemostasis , especially high-risk lesion . High-risk lesion include peptic ulcer active spurt vessel , ooze vessel , NBVV , nonbleeding visible vessel . Current modality endoscopic hemostasis include epinephrine injection , endoscopic coaptive thermocoagulation , hemoclipping . Endoscopic hemostasis document number clinical study effective decrease rebleeding , need emergency surgery , decrease hospitalization day . Current evidence also show combination therapy epinephrine injection heater probe thermocoagulation/hemo-clip hemostasis effective epinephrine injection alone heater probe thermocoagulation alone , hemoclip hemostasis alone . Studies show high dose intravenous proton pump inhibitor infusion initial endoscopic hemostasis reduce recurrent ulcer bleeding . However , still controversial whether adjuvant use standard-dose proton pump inhibitor therapy endoscopic therapy similar benefit . We hypothesize adjuvant use standard dose proton pump inhibitor combine endoscopic hemostasis therapy offer similar benefit high dose proton pump inhibitor .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Peptic Ulcer</mesh_term>
	<mesh_term>Peptic Ulcer Hemorrhage</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<criteria>adult age 16 year old acute nonvariceal upper gastrointestinal bleeding read , agree attend study , sign informed consent indicate receive esophagogastroduodenoscopy ( EGD ) peptic ulcer high risk lesion ( active bleeding : spurting , ooze peptic ulcer . Ulcers NBVV : nonbleeding visible vessel ) unable receive EGD ( unable open mouth , upper gastrointestinal obstruction ) bleeding tendency ( platelet &lt; 50x109/L , prothrombin time INR &gt; 2 , ongoing use heparin coumadin ) gastric malignancy myocardial infarction within recent one week recent cerebrovascular event within recent one week pregnancy refuse attend study know allergy history epinephrine pantoprazole</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Endoscopic treatment</keyword>
	<keyword>Peptic ulcer</keyword>
	<keyword>Bleeding</keyword>
	<keyword>Thermocoagulation</keyword>
	<keyword>Proton pump inhibitor</keyword>
</DOC>